SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001615774-18-012638
Filing Date
2018-11-14
Accepted
2018-11-14 11:06:12
Documents
68
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q s113888_10q.htm 10-Q 780180
2 EXHIBIT 31.1 s113888_ex31-1.htm EX-31.1 13504
3 EXHIBIT 32.1 s113888_ex32-1.htm EX-32.1 5968
  Complete submission text file 0001615774-18-012638.txt   5113083

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE bthe-20180930.xml EX-101.INS 898939
5 XBRL SCHEMA FILE bthe-20180930.xsd EX-101.SCH 53022
6 XBRL CALCULATION FILE bthe-20180930_cal.xml EX-101.CAL 54855
7 XBRL DEFINITION FILE bthe-20180930_def.xml EX-101.DEF 293358
8 XBRL LABEL FILE bthe-20180930_lab.xml EX-101.LAB 445840
9 XBRL PRESENTATION FILE bthe-20180930_pre.xml EX-101.PRE 378188
Mailing Address 354 MERRIMACK STREET #4 LAWRENCE MA 01843
Business Address 354 MERRIMACK STREET #4 LAWRENCE MA 01843 (603) 935-9799
Boston Therapeutics, Inc. (Filer) CIK: 0001473579 (see all company filings)

IRS No.: 270801073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54586 | Film No.: 181181424
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1